8:30 a.m. - 9:00 a.m.

Registration
(American Association for the Advancement of Science)

9:00 a.m. - 9:15 a.m.

Welcome
Edward Abrahams
Executive Director, PMC

Introductory Remarks
Stephen Fodor, Executive Chairman of the Board, Affymetrix

9:15 a.m. - 10:00 a.m.

Setting the Stage
ROI in Personalized Medicine: Pathways and Barriers

Speaker:
Paul Keckley, Executive Director, Deloitte Center for Health Solutions [Study | Slides]

10:00 a.m. – 12:00 p.m.

Perspectives Panel
Moderator: Paul Keckley

Speakers:

Aidan C. Power, Vice President & Global Head of Molecular Medicine, Pfizer Global Research and Development [Slides]

Randy Scott, Chairman and CEO, Genomic Health [Slides]

James Utley, Vice President and Medical Director of the Commercial Business Division, Coventry Health Care [Slides]

12:00 – 12:15 p.m.

Q&A session with panel

12:15 – 12:30 p.m.

Transition to Luncheon

12:30 – 1:45 p.m.

Luncheon
(Grand Hyatt Washington)
Bridging the Gap: Healthcare Reform and Its Potential Impact on the Development and Adoption of Personalized Medicine

Speaker:
The Honorable W. J. Billy Tauzin, President and Chief Executive Officer, Pharmaceutical Research and Manufacturers of America (PhRMA) (invited)

1:45 – 2:00 p.m.

Transition to AAAS

2:00 – 3:45 pm

Policy Discussion
A National Leadership Perspective on Personalized Medicine

Speaker:
Francis Collins, Former Director of National Human Genome Research Institute, National Institutes of Health [Slides]

3:45 – 4:30 p.m.

Policy Discussion
The Critical Path Initiative: Breaking Down Barriers at FDA

Speaker:
Janet Woodcock, Director, Center for Drug Evaluation and Research, FDA [Slides]

4:30 – 4:45 p.m.

Q&A with Policy Speakers

4:45 – 5:00 p.m.

Summary and Closing Remarks

Speaker:
Wayne Rosenkrans, Jr.
Chairman and President, Personalized Medicine Coalition; Distinguished Fellow, MIT Center for Biomedical Innovation; Chief Applications Officer, SciTech Strategies

5:00 – 7:00 p.m.

Reception
(American Association for the Advancement of Science)